
Joe Raedle / Getty Images
September 21, 2016 - Within the last decade, Mylan Pharmaceuticals has increased the price for EpiPens -- its life-saving, epinephrine-based allergy treatment -- from less than $100 to almost $610. Amid the ensuing furor, more attention has been paid to Mylan’s business tactics than to its political activity. Read more